Literature DB >> 531276

[Hematin treatment of acute intermittent porphyria. A case report (author's transl)].

P E Marchiori, J L de Assis, M Scaff, L G Do Serro-Azul, E C Moraes, L A Bacheschi, N Yassuda.   

Abstract

A young woman with acute intermittent porphyria in profound relapse and severe nervous and respiratory involvement was treated by intravenous infusions of hematin, followed by improvement of symptoms. The diet with high carbohydrate and protein content and a B-adrenergic blocking agent, not showed any beneficial effect on acute attack. The infusion of hematin was followed by a lowering effect on urine porphybilinogen and delta-aminolevulinic acid and clinical improvement. The return to normal of porphyrin precursors in the urine was accompanied by almost complete clinical remission. The relationship of remission and repression of delta-aminolevulinic acid, decrease of urinary levels of porphyrin precursors, pulmonaries tests and electromyograms, were discussed.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 531276

Source DB:  PubMed          Journal:  Rev Bras Pesqui Med Biol        ISSN: 0034-7310


  1 in total

1.  Hematin therapy in porphyric attacks.

Authors:  C A Pierach; I Bossenmaier; R Cardinal; M Weimer; C J Watson
Journal:  Klin Wochenschr       Date:  1980-08-15
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.